AltMountain

Blackstone Life Sciences V Access Fund, L.P.

New York, NY · CIK 1817675
Status: no Form D since Sep 2020. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Blackstone Life Sciences V Access Fund, L.P. is a private equity fund based in New York, New York. According to its most recent Form D, filed Sep 18, 2020, it has sold $383,868,991 of interests to 1,883 investors since its first sale in Jul 2020. The minimum investment it accepts from an outside investor is $100,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Maples Fiduciary Services (Delaware) Inc; iCapital Alternative Investments LLC; Edward Truitt, Jr.

Total raised
$383,868,991Cumulative sales reported on Form D
Investors
1,883
First sale
Jul 6, 2020
Minimum investment
$100,000
Who can invest
Qualified purchasersSection 3(c)(7): generally $5M+ in investments
Offering exemption
Rule 506(b)No general advertising
Key people and entities
Maples Fiduciary Services (Delaware) Inc; iCapital Alternative Investments LLC; Edward Truitt, Jr
Latest Form D
Sep 18, 2020

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌​‌‌‌‌‌‌‌‌‌​⁠

Raise history

FiledFilingTotal raisedInvestorsSource
Sep 18, 2020Form D/A (amendment)$383,868,9911,883SEC.gov ↗
Jul 10, 2020Form D$01,883SEC.gov ↗

2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jul 10, 2020. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.

Questions about Blackstone Life Sciences V Access Fund, L.P.

What is the minimum investment for Blackstone Life Sciences V Access Fund, L.P.?

According to its latest Form D, filed Sep 18, 2020, the minimum investment Blackstone Life Sciences V Access Fund, L.P. accepts from an outside investor is $100,000.

Who can invest in Blackstone Life Sciences V Access Fund, L.P.?

Blackstone Life Sciences V Access Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.

How much has Blackstone Life Sciences V Access Fund, L.P. raised?

Blackstone Life Sciences V Access Fund, L.P. reports $383,868,991 sold from 1,883 investors on its Form D filed Sep 18, 2020. This is cumulative sales since the offering began, not current assets or performance.

Where is Blackstone Life Sciences V Access Fund, L.P. based?

Blackstone Life Sciences V Access Fund, L.P. is based in New York, New York.

When did Blackstone Life Sciences V Access Fund, L.P. launch?

Blackstone Life Sciences V Access Fund, L.P. reports its first sale in Jul 2020.

Size compared with every private equity fund

Raised more than 88% of the 3,661 private equity funds based in New York, and more than 87% of all 8,931 that report sales.

Other funds with the same team

More private equity funds in New York

Similar-size private equity funds in New York

All private equity funds in New York